Both splicing variants of the dopamine D2 receptor mRNA are up-regulated by antipsychotic drugs
- 5 February 1993
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 150 (1) , 25-28
- https://doi.org/10.1016/0304-3940(93)90099-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatmentPsychopharmacology, 1992
- Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatmentNeuroscience Research, 1991
- Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the ratMolecular Brain Research, 1991
- Simultaneous quantification of several mRNA species by solution hybridisation with oligonucleotidesNucleic Acids Research, 1991
- Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatmentEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Two D2 dopamine receptor isoforms generated via alternative mRNA splicing: regional distribution and effects of haloperidol treatmentsEuropean Journal of Pharmacology, 1990
- Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA levelNeuroscience Letters, 1990
- Organization and expression of the Rat D2A receptor gene: identification of alternative transcripts and a variant donor splice siteBiochemistry, 1990
- Multiple D2 dopamine receptors produced by alternative RNA splicingNature, 1989
- Alternative splicing directs the expression of two D2 dopamine receptor isoformsNature, 1989